{
  "success": true,
  "sourceFile": "input/Alexion_NCT04573309_Wilsons_SAP.pdf",
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33
  ],
  "modelUsed": "gemini-2.5-pro",
  "sapData": {
    "analysisPopulations": [
      {
        "id": "pop_1",
        "name": "Screened Set",
        "populationType": "Other",
        "instanceType": "AnalysisPopulation",
        "description": "All participants who signed an informed consent form (ICF).",
        "criteria": "Signed an informed consent form"
      },
      {
        "id": "pop_2",
        "name": "Enrolled Set",
        "populationType": "Other",
        "instanceType": "AnalysisPopulation",
        "description": "All participants who were enrolled in the study.",
        "criteria": "Enrolled in the study"
      },
      {
        "id": "pop_3",
        "name": "Full Analysis Set",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "FA",
        "description": "All participants who were enrolled and received at least 1 dose of study drug. The FA Set will be the primary population for all efficacy analyses.",
        "criteria": "Enrolled and received at least 1 dose of study drug"
      },
      {
        "id": "pop_4",
        "name": "Per Protocol Set",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "PP",
        "description": "All participants in the FA Set who have no major protocol deviations that would impact the primary efficacy endpoint. The PP Set will be used for sensitivity analyses of the primary efficacy endpoint.",
        "criteria": "Member of FA Set with no major protocol deviations impacting the primary efficacy endpoint"
      },
      {
        "id": "pop_5",
        "name": "Safety Set",
        "populationType": "Safety",
        "instanceType": "AnalysisPopulation",
        "description": "All participants who received at least 1 dose of study drug. The Safety Set will be used for all safety analyses.",
        "criteria": "Received at least 1 dose of study drug"
      },
      {
        "id": "pop_6",
        "name": "Pharmacokinetic Analysis Set",
        "populationType": "PK",
        "instanceType": "AnalysisPopulation",
        "label": "PK",
        "description": "All participants in the Safety Set who have sufficient plasma concentration data to derive at least 1 PK parameter. The PK Analysis Set will be used for all PK analyses.",
        "criteria": "Member of Safety Set with sufficient plasma concentration data to derive at least 1 PK parameter"
      },
      {
        "id": "pop_7",
        "name": "Pharmacodynamic Analysis Set",
        "populationType": "PD",
        "instanceType": "AnalysisPopulation",
        "label": "PD",
        "description": "All participants in the Safety Set who have sufficient PD data to derive at least 1 PD parameter. The PD Analysis Set will be used for all PD analyses.",
        "criteria": "Member of Safety Set with sufficient PD data to derive at least 1 PD parameter"
      }
    ],
    "characteristics": [
      {
        "id": "char_1",
        "name": "Age",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Age will be calculated as of the date of informed consent."
      },
      {
        "id": "char_2",
        "name": "Sex",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Sex of the participant."
      },
      {
        "id": "char_3",
        "name": "Race",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Race of the participant."
      },
      {
        "id": "char_4",
        "name": "Ethnicity",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Ethnicity of the participant."
      },
      {
        "id": "char_5",
        "name": "Time since diagnosis of Wilson Disease",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Time since diagnosis of Wilson Disease (WD)."
      },
      {
        "id": "char_6",
        "name": "Baseline Wilson Disease therapy",
        "dataType": "Text",
        "instanceType": "Characteristic",
        "description": "Wilson Disease (WD) therapy at baseline."
      },
      {
        "id": "char_7",
        "name": "Baseline ceruloplasmin",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Baseline laboratory value for ceruloplasmin."
      },
      {
        "id": "char_8",
        "name": "Baseline serum copper",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Baseline laboratory value for serum copper."
      },
      {
        "id": "char_9",
        "name": "Baseline 24-hour urine copper",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Baseline laboratory value for 24-hour urine copper."
      },
      {
        "id": "char_10",
        "name": "Medical History",
        "dataType": "Text",
        "instanceType": "Characteristic",
        "description": "Medical history will be coded using the Medical Dictionary for Regulatory Activities (MedDRA) and summarized by system organ class (SOC) and preferred term (PT)."
      },
      {
        "id": "char_11",
        "name": "Surgical History",
        "dataType": "Text",
        "instanceType": "Characteristic",
        "description": "Surgical history will be coded using the Medical Dictionary for Regulatory Activities (MedDRA) and summarized by system organ class (SOC) and preferred term (PT)."
      },
      {
        "id": "char_12",
        "name": "Prior medications for Wilson Disease",
        "dataType": "Text",
        "instanceType": "Characteristic",
        "description": "Prior medications used to treat Wilson Disease (WD) will be summarized separately."
      },
      {
        "id": "char_13",
        "name": "Body Mass Index",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Body mass index (BMI) will be calculated as weight (kg) / [height (m)]^2."
      }
    ],
    "summary": {
      "populationCount": 7,
      "characteristicCount": 13
    }
  }
}